Heart Failure Stage | |||||
---|---|---|---|---|---|
Total | A | B | C | p | |
N (%) | 509 | 20 (3.9) | 264 (51.9) | 225 (44.2) | |
LVEF (%), median (IQR) | 58 (53–62) | 64 (58–67) | 59 (55–63) | 56 (50–61) | <0.0011 |
LVEF categories, n (%) | |||||
< 30% | 7 (1.4) | 0 | 2 (0.8) | 5 (2.3) | 0.0412 |
30–39% | 23 (4.5) | 0 | 10 (3.8) | 13 (6.1) | |
40–52% | 80 (15.6) | 1 (5.0) | 32 (12.1) | 43 (20.1) | |
> 52% | 402 (78.5) | 19 (95.0) | 220 (83.3) | 153 (71.5) | |
Wall motion abnormalities, n (%) | 138 (28.1) | 2 (10.0) | 59 (23.4) | 74 (35.7) | 0.0032 |
LVEDVI (ml/m2), median (IQR) | 60 (50–72) | 49 (40–56) | 60 (50–69) | 61 (53–79) | <0.0011 |
LV mass index (g/m2), median (IQR) | 93 (78–110) | 82 (64–95) | 92 (77–108) | 99 (82–120) | <0.0011 |
LAA (cm2), median (IQR) | 20 (17–23) | 18 (16–20) | 20 (17–23) | 20 (17–24) | 0.0381 |
E/e´, median (IQR) | 9 (7.2–11.4) | 6.8 (5.5–8.4) | 8.8 (7.2–10.8) | 9.5 (7.5–12.1) | <0.0011 |